Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Brain imaging evidence of preclinical Alzheimer's disease in normal aging.

Jagust W, Gitcho A, Sun F, Kuczynski B, Mungas D, Haan M.

Ann Neurol. 2006 Apr;59(4):673-81.

2.

Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer's disease in a community: the Osaki-Tajiri Project.

Ishii H, Ishikawa H, Meguro K, Tashiro M, Yamaguchi S.

Int Psychogeriatr. 2009 Feb;21(1):148-56. doi: 10.1017/S1041610208008132. Epub 2008 Dec 1.

PMID:
19040787
3.

Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.

Arlt S, Buchert R, Spies L, Eichenlaub M, Lehmbeck JT, Jahn H.

Eur Arch Psychiatry Clin Neurosci. 2013 Jun;263(4):335-44. doi: 10.1007/s00406-012-0350-7. Epub 2012 Sep 1.

PMID:
22940716
4.

Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative.

Koppel J, Sunday S, Goldberg TE, Davies P, Christen E, Greenwald BS; Alzheimer's Disease Neuroimaging Initiative..

Am J Geriatr Psychiatry. 2014 Jul;22(7):698-707. doi: 10.1016/j.jagp.2012.10.028. Epub 2013 Mar 15.

PMID:
23672944
5.

Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.

Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM.

Am J Psychiatry. 2002 May;159(5):738-45.

PMID:
11986126
6.

White matter integrity and cortical metabolic associations in aging and dementia.

Kuczynski B, Targan E, Madison C, Weiner M, Zhang Y, Reed B, Chui HC, Jagust W.

Alzheimers Dement. 2010 Jan;6(1):54-62. doi: 10.1016/j.jalz.2009.04.1228.

7.

FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment.

Chételat G, Eustache F, Viader F, De La Sayette V, Pélerin A, Mézenge F, Hannequin D, Dupuy B, Baron JC, Desgranges B.

Neurocase. 2005 Feb;11(1):14-25.

PMID:
15804920
8.

Cognitive and anatomic contributions of metabolic decline in Alzheimer disease and cerebrovascular disease.

Kuczynski B, Reed B, Mungas D, Weiner M, Chui HC, Jagust W.

Arch Neurol. 2008 May;65(5):650-5. doi: 10.1001/archneur.65.5.650.

9.

Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease.

Fouquet M, Desgranges B, Landeau B, Duchesnay E, Mézenge F, de la Sayette V, Viader F, Baron JC, Eustache F, Chételat G.

Brain. 2009 Aug;132(Pt 8):2058-67. doi: 10.1093/brain/awp132. Epub 2009 May 28.

10.

Relations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer's disease: a PET/MRI correlative study.

Meguro K, LeMestric C, Landeau B, Desgranges B, Eustache F, Baron JC.

J Neurol Neurosurg Psychiatry. 2001 Sep;71(3):315-21.

11.

A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline.

den Heijer T, van der Lijn F, Koudstaal PJ, Hofman A, van der Lugt A, Krestin GP, Niessen WJ, Breteler MM.

Brain. 2010 Apr;133(Pt 4):1163-72. doi: 10.1093/brain/awq048.

PMID:
20375138
12.

Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.

Hunt A, Schönknecht P, Henze M, Seidl U, Haberkorn U, Schröder J.

Psychiatry Res. 2007 Jul 15;155(2):147-54. Epub 2007 May 23.

PMID:
17524628
13.

Free and cued memory in relation to biomarker-defined abnormalities in clinically normal older adults and those at risk for Alzheimer's disease.

Papp KV, Amariglio RE, Mormino EC, Hedden T, Dekhytar M, Johnson KA, Sperling RA, Rentz DM.

Neuropsychologia. 2015 Jul;73:169-75. doi: 10.1016/j.neuropsychologia.2015.04.034. Epub 2015 May 19.

14.

Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.

Small GW, Siddarth P, Kepe V, Ercoli LM, Burggren AC, Bookheimer SY, Miller KJ, Kim J, Lavretsky H, Huang SC, Barrio JR.

Arch Neurol. 2012 Feb;69(2):215-22. doi: 10.1001/archneurol.2011.559.

15.

Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.

Willette AA, Bendlin BB, Starks EJ, Birdsill AC, Johnson SC, Christian BT, Okonkwo OC, La Rue A, Hermann BP, Koscik RL, Jonaitis EM, Sager MA, Asthana S.

JAMA Neurol. 2015 Sep;72(9):1013-20. doi: 10.1001/jamaneurol.2015.0613. Erratum in: JAMA Neurol. 2015 Dec;72(12):1537.

16.

Brain [18F]FDDNP binding and glucose metabolism in advanced elderly healthy subjects and Alzheimer's disease patients.

Tauber C, Beaufils E, Hommet C, Ribeiro MJ, Vercouillie J, Vierron E, Mondon K, Cottier JP, Gissot V, Guilloteau D, Camus V.

J Alzheimers Dis. 2013;36(2):311-20. doi: 10.3233/JAD-122068.

PMID:
23609763
17.

Cerebral metabolic correlates of four dementia scales in Alzheimer's disease.

Salmon E, Lespagnard S, Marique P, Peeters F, Herholz K, Perani D, Holthoff V, Kalbe E, Anchisi D, Adam S, Collette F, Garraux G.

J Neurol. 2005 Mar;252(3):283-90. Epub 2005 Feb 23. Erratum in: J Neurol. 2005 Sep;252(9):1138.

PMID:
16189724
18.

Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer's disease using FDG-PET.

Mosconi L, De Santi S, Li Y, Li J, Zhan J, Tsui WH, Boppana M, Pupi A, de Leon MJ.

Eur J Nucl Med Mol Imaging. 2006 Feb;33(2):210-21. Epub 2005 Nov 26.

PMID:
16311757
19.

Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.

Villemagne VL, Pike KE, Darby D, Maruff P, Savage G, Ng S, Ackermann U, Cowie TF, Currie J, Chan SG, Jones G, Tochon-Danguy H, O'Keefe G, Masters CL, Rowe CC.

Neuropsychologia. 2008;46(6):1688-97. doi: 10.1016/j.neuropsychologia.2008.02.008. Epub 2008 Feb 14.

PMID:
18343463
20.

Metabolic correlates of Rey auditory verbal learning test in elderly subjects with memory complaints.

Brugnolo A, Morbelli S, Arnaldi D, De Carli F, Accardo J, Bossert I, Dessi B, Famà F, Ferrara M, Girtler N, Picco A, Rodriguez G, Sambuceti G, Nobili F.

J Alzheimers Dis. 2014;39(1):103-13. doi: 10.3233/JAD-121684.

PMID:
24150105

Supplemental Content

Support Center